Home › Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration With Bayer
 

Keywords :   


Seattle Genetics Enters Into New Antibody-Drug Conjugate Collaboration With Bayer

2013-06-25 09:00:00| drugdiscoveryonline News Articles

Seattle Genetics, Inc. recently announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer)

Tags: with collaboration seattle enters

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
25.11Dr.
25.112BOX
25.11 Bianchi roma4
25.11PS3 CECH-2000A HDD1TB
25.11
25.11
25.11SUN FRAME B2 51.5×72.8cm
25.11 Jack Bunny
More »